📰 Interim Analysis News
Page 6 - Interim Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interim Analysis. Real-time updates on events, politics, business and more.
November 3, 2022
Investegate announcements from F. Hoffmann-La Roche Ltd, Roche to present data at ASH 2022 showcasing strength of haematology portfolio and expanding into new areas to address more patient needs
November 2, 2022
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
November 2, 2022
The second round of late-breaking clinical trial results were presented at VIVA22 on Nov. 1 in Las Vegas, NV.
November 1, 2022
Gilead to Present Data Across Viral Hepatitis and Liver Fibrosis at The Liver Meeting® 2022, Reinforcing Gilead as a Leader in Addressing Treatment Needs for People Living With Liver Disease
October 31, 2022
Conference Call and Webcast to discuss the new data being presented at AASLD scheduled for 8:45 AM ET, Friday, November 4, 2022
October 31, 2022
/PRNewswire/ -- GenesisCare, a leading provider of integrated cancer care globally, and Prelude Corporation (PreludeDx(TM)), a leader in molecular diagnostics...
October 30, 2022
/PRNewswire/ -- GenesisCare, a leading provider of integrated cancer care globally, and Prelude Corporation (PreludeDx(TM)), a leader in molecular diagnostics...
October 26, 2022
Final safety and efficacy results from the Phase 3 EVOLVE-MS-1 trial demonstrate decreases in disease activity and favorable tolerability for VUMERITY (diroximel fumarate) consistent with previous
October 12, 2022
First presentation of RSV Older Adult vaccine candidates pivotal phase III efficacy and safety data New data showing Shingrix... | October 12, 2022
September 22, 2022
Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease Ongoing Positive Interim Analysis – DMC Recommended Study Sample Size of 350 Patients Topline...